Central Glass (4044) Investor update summary
Event summary combining transcript, slides, and related documents.
Investor update summary
21 Oct, 2026Business overview
FY2025 forecast electronic materials sales of ¥248億, versus ¥242億 in FY2024; semiconductor gases accounted for 80% of FY2024 sales.
Portfolio serves semiconductor front-end processes with high-purity process and etching gases, photoresist materials and pattern-collapse preventers.
AI-related demand is driving semiconductor market growth, with logic-oriented products supporting recent sales expansion.
Competitive strengths
Longstanding joint development with semiconductor and equipment makers supports product differentiation and proprietary materials.
Two overseas and two domestic research centers connect development, medium-volume production and mass-production facilities to accelerate commercialization.
Integrated production from fluorite to finished products supports supply-chain resilience; overseas sales and manufacturing networks are strongest in Taiwan and South Korea.
Strategy and growth targets
Phase 1 (FY2025–FY2027): expand high-function materials with environmental performance, strengthen existing products and sales, and develop manufacturing bases in Taiwan and South Korea.
Phase 2 (FY2028–FY2030): enter new markets and expand global sales and production bases, backed by selected development themes and growth investment.
Electronic materials sales target: ¥470億 by FY2030, supported by successive launches of new and existing products.
Latest events from Central Glass
- Higher H1 sales masked sharp profit declines, prompting lower FY2023 guidance.4044
Q2 2023 - Sales growth was offset by lower operating profit and net income.4044
Q1 2023 - FY2023 beat profit forecasts, but FY2024 earnings are expected to retreat.4044
Q4 2023 - Stronger glass sales could not offset lower chemical earnings and reduced extraordinary income.4044
Q3 2023 - Sales fell 10.7%, but operating profit rose on LCM support; FY guidance was unchanged.4044
Q1 2024 - Weak demand cut nine-month results and FY2024 forecasts; the ¥170 dividend was maintained.4044
Q3 2024 - H1 earnings fell on weaker demand and a share-sale loss; FY guidance was unchanged.4044
Q2 2024 - FY2025 sales edge higher, but operating profit falls amid weak demand and tariffs.4044
Q4 2024 - H1 operating profit fell 47.3% amid electrolyte pressure; FY2025 guidance was cut.4044
Q2 2025